Sage Therapeutics And Biogen Complete Rolling Submission Of New Drug Application For Zuranolone

Published on December 06, 2022 03:31 AM PST

Dec 6 (Reuters) - Biogen Inc:

* SAGE THERAPEUTICS AND BIOGEN COMPLETE ROLLING SUBMISSION OF NEW DRUG APPLICATION FOR ZURANOLONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER AND POSTPARTUM DEPRESSION

* BIOGEN INC - SUBMISSION COMPLETES NDA FILING THAT WAS INITIATED EARLIER THIS YEAR Source text for Eikon: Further company coverage:

Reuters

Reuters -
96361 Posts
...

Disclaimer

The above content is directly sourced from Reuters under a contractual arrangement. The content is being provided as a convenience and for informational purposes only; and does not constitute an endorsement or approval by Kalkine Media of any of the products, services, or opinions of the organization or individual. The user is apprised that Kalkine Media bears no responsibility for the accuracy, legality, or content of Reuters, any external sites, or for that of subsequent links. The user is requested to contact Reuters directly for answers to questions regarding the content. Please note that Kalkine Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.